Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA polymerases are essential enzymes that catalyze the synthesis of DNA molecules from deoxyribonucleotides, playing a central role in DNA replication and repair (UniProt). They function by adding nucleotides to the 3'-OH end of a growing DNA strand, guided by a template strand (NIH). In therapeutic contexts, the DNA polymerase active site is a major target for antiviral and anticancer drugs (PubChem). Nucleoside analogs, such as acyclovir and cytarabine, act as suicide substrates that are incorporated into the DNA, leading to chain termination or inhibition of further synthesis (StatPearls). Because cancer cells and viruses rely heavily on rapid DNA replication, these inhibitors can selectively disrupt their proliferation (PubMed). However, challenges include off-target effects on host cell polymerases, such as mitochondrial DNA polymerase gamma, which can lead to significant toxicities like myelosuppression and organ damage (NIH).
Drugs targeting DNA polymerases primarily act as nucleoside or nucleotide analogs that compete with natural substrates for the active site. Upon incorporation into the nascent DNA strand, they typically cause premature chain termination or inhibit the enzyme's catalytic activity. Other mechanisms include allosteric inhibition and mimicry of pyrophosphate to block the release of the byproduct during nucleotide addition.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA polymerase (DNAP) (DNAP).